These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 19512976

  • 1. Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
    Bokde AL, Karmann M, Teipel SJ, Born C, Lieb M, Reiser MF, Möller HJ, Hampel H.
    J Clin Psychopharmacol; 2009 Apr; 29(2):147-56. PubMed ID: 19512976
    [Abstract] [Full Text] [Related]

  • 2. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R, Scheltens P, Barkhof F, Rombouts SA.
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [Abstract] [Full Text] [Related]

  • 3. Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study.
    Goekoop R, Rombouts SA, Jonker C, Hibbel A, Knol DL, Truyen L, Barkhof F, Scheltens P.
    Neuroimage; 2004 Dec; 23(4):1450-9. PubMed ID: 15589109
    [Abstract] [Full Text] [Related]

  • 4. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
    Bokde AL, Lopez-Bayo P, Meindl T, Pechler S, Born C, Faltraco F, Teipel SJ, Möller HJ, Hampel H.
    Brain; 2006 May; 129(Pt 5):1113-24. PubMed ID: 16520329
    [Abstract] [Full Text] [Related]

  • 5. Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.
    Teipel SJ, Bokde AL, Born C, Meindl T, Reiser M, Möller HJ, Hampel H.
    Brain; 2007 Jul; 130(Pt 7):1745-58. PubMed ID: 17566054
    [Abstract] [Full Text] [Related]

  • 6. Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: an fMRI study.
    Bokde AL, Lopez-Bayo P, Born C, Dong W, Meindl T, Leinsinger G, Teipel SJ, Faltraco F, Reiser M, Möller HJ, Hampel H.
    Psychiatry Res; 2008 Aug 30; 163(3):248-59. PubMed ID: 18672352
    [Abstract] [Full Text] [Related]

  • 7. Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease.
    Shanks MF, McGeown WJ, Forbes-McKay KE, Waiter GD, Ries M, Venneri A.
    Magn Reson Imaging; 2007 Jul 30; 25(6):848-59. PubMed ID: 17442521
    [Abstract] [Full Text] [Related]

  • 8. Alzheimer disease: functional abnormalities in the dorsal visual pathway.
    Bokde AL, Lopez-Bayo P, Born C, Ewers M, Meindl T, Teipel SJ, Faltraco F, Reiser MF, Möller HJ, Hampel H.
    Radiology; 2010 Jan 30; 254(1):219-26. PubMed ID: 20032154
    [Abstract] [Full Text] [Related]

  • 9. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW, Yik PY, Mok W, Chung CP.
    Int J Clin Pract; 2007 Mar 30; 61(3):403-10. PubMed ID: 17313606
    [Abstract] [Full Text] [Related]

  • 10. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.
    Penner J, Rupsingh R, Smith M, Wells JL, Borrie MJ, Bartha R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):104-10. PubMed ID: 19833161
    [Abstract] [Full Text] [Related]

  • 11. Treatment effects of therapeutic cholinesterase inhibitors on visuospatial processing in Alzheimer's disease: a longitudinal functional MRI study.
    Thiyagesh SN, Farrow TF, Parks RW, Accosta-Mesa H, Hunter MD, Young C, Wilkinson ID, Woodruff PW.
    Dement Geriatr Cogn Disord; 2010 Feb 01; 29(2):176-88. PubMed ID: 20215749
    [Abstract] [Full Text] [Related]

  • 12. Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
    Mega MS, Dinov ID, Porter V, Chow G, Reback E, Davoodi P, O'Connor SM, Carter MF, Amezcua H, Cummings JL.
    Arch Neurol; 2005 May 01; 62(5):721-8. PubMed ID: 15883258
    [Abstract] [Full Text] [Related]

  • 13. Update on Alzheimer drugs (galantamine).
    Raskind MA.
    Neurologist; 2003 Sep 01; 9(5):235-40. PubMed ID: 12971834
    [Abstract] [Full Text] [Related]

  • 14. The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.
    Chankrachang S, Senanarong V, Poungvarin N, Phanthumchinda K, Tavichachart N, Praditsuwan R, Nidhinandana S.
    J Med Assoc Thai; 2008 Sep 01; 91(9):1343-9. PubMed ID: 18843862
    [Abstract] [Full Text] [Related]

  • 15. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity.
    Sauer J, ffytche DH, Ballard C, Brown RG, Howard R.
    Brain; 2006 Jul 01; 129(Pt 7):1780-8. PubMed ID: 16670180
    [Abstract] [Full Text] [Related]

  • 16. Failure to modulate neural response to increased task demand in mild Alzheimer's disease: fMRI study of visuospatial processing.
    Vannini P, Lehmann C, Dierks T, Jann K, Viitanen M, Wahlund LO, Almkvist O.
    Neurobiol Dis; 2008 Sep 01; 31(3):287-97. PubMed ID: 18619845
    [Abstract] [Full Text] [Related]

  • 17. Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing.
    Vannini P, Almkvist O, Dierks T, Lehmann C, Wahlund LO.
    Psychiatry Res; 2007 Oct 15; 156(1):43-57. PubMed ID: 17719211
    [Abstract] [Full Text] [Related]

  • 18. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.
    Vellas B, Cunha L, Gertz HJ, De Deyn PP, Wesnes K, Hammond G, Schwalen S, GAL-INT-28 Study Group.
    Curr Med Res Opin; 2005 Sep 15; 21(9):1423-9. PubMed ID: 16197661
    [Abstract] [Full Text] [Related]

  • 19. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment.
    Saykin AJ, Wishart HA, Rabin LA, Flashman LA, McHugh TL, Mamourian AC, Santulli RB.
    Brain; 2004 Jul 15; 127(Pt 7):1574-83. PubMed ID: 15140813
    [Abstract] [Full Text] [Related]

  • 20. [Galantamine: a novel cholinergic agent for Alzheimer's disease].
    Olazarán J, García G.
    Neurologia; 2002 Oct 15; 17(8):429-36. PubMed ID: 12396973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.